Plunkett Research Online: Chemomab Therapeutics Ltd

CHEMOMAB THERAPEUTICS LTD (CMMB:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet need. The company's lead candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlyi.....



Chemomab Therapeutics Ltd
Ticker: CMMB
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 972-77-3310156
Fax:
Address: Kiryat Atidim
Building 7
Tel Aviv, 6158002 Israel

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Development & Manufacturing
Clinical-Stage Biotechnology
Therapeutic Development
Inflammation
Fibrosis
Contacts Description
Dale Pfost CEO/Chairman of the Board/Director
Donald Marvin CFO/COO/Executive VP
See More
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet need. The company's lead candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlyi.....See More See More

Auditor: KPMG Somekh Chaikin
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2021 2020
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
CM-101
Chemomab Ltd
Anchiano Therapeutics Ltd
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: